Key Insights

Highlights

Treatment Research

2 treatments under study, led by Case Patients Colonized Rectally With Esblproducing Enterobacteriaceae With Antibiotic Pressure

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT04699981Not ApplicableUnknownPrimary

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?

Showing all 1 trials

Research Network

Common Treatments

  • Case Patients Colonized Rectally With Esblproducing Enterobacteriaceae With Antibiotic Pressure1
  • Control Patients Colonized Rectally With Esblproducing Enterobacteria Without Antibiotic Pressure1

Active Sponsors

  • Fondation Hôpital Saint-Joseph1

Top Investigators

Activity Timeline